Benign neoplasm of mesothelial tissue of peritoneum
ICD-10 D19.1 is a billable code used to indicate a diagnosis of benign neoplasm of mesothelial tissue of peritoneum.
Benign neoplasms of mesothelial tissue of the peritoneum are non-cancerous growths that arise from the mesothelial cells lining the peritoneal cavity. These neoplasms can present as localized masses or diffuse thickening of the peritoneum. Clinically, they may be asymptomatic or cause symptoms such as abdominal pain, distension, or bowel obstruction depending on their size and location. Diagnosis typically involves imaging studies such as ultrasound or CT scans, and may require biopsy for definitive histological confirmation. While benign, these neoplasms should be monitored due to their potential for local complications and, in rare cases, transformation into malignant forms. Regular follow-up and imaging may be warranted to assess for changes in size or characteristics, ensuring timely intervention if necessary.
Detailed pathology reports and imaging studies must be documented to support the diagnosis.
Patients presenting with abdominal masses or unexplained abdominal symptoms.
Ensure that any imaging or biopsy results are clearly linked to the diagnosis to avoid misclassification.
Endoscopic findings and imaging results should be documented to provide a comprehensive view of the patient's condition.
Patients with chronic abdominal pain or unexplained gastrointestinal symptoms.
Documentation should include any relevant history of prior abdominal surgeries or conditions that may affect the peritoneum.
Used when a patient with a suspected abdominal mass undergoes surgery for diagnosis.
Operative reports must detail findings and any biopsies taken.
Surgeons should document the rationale for surgery and any findings related to the neoplasm.
Common symptoms may include abdominal pain, distension, and bowel obstruction, although many patients may be asymptomatic.
Surveillance frequency depends on the size and symptoms of the neoplasm, but regular follow-up imaging is generally recommended.